Fatigue, symptom burden, and health‐related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria

Fatigue, symptom burden, and health‐related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria

Abstract Background Fatigue is distressing and affects quality of life (QoL) among patients with myelodysplastic syndrome (MDS), aplastic anemia (AA), and paroxysmal nocturnal hemoglobinuria (PNH). Limited data exist on the impact of fatigue, QoL, and related symptoms in these patients. Objective Pr...

Full description

Bibliographic Details
Main Authors: Carmen P. Escalante, Stephanie Chisolm, Juhee Song, Marsha Richardson, Ellen Salkeld, Etsuko Aoki, Guillermo Garcia‐Manero
Format: Article
Language:English
Published: Wiley 2019-02-01
Series:Cancer Medicine
Subjects:
aplastic anemia
fatigue
myelodysplastic syndrome
paroxysmal nocturnal hematuria
quality of life
Online Access:https://doi.org/10.1002/cam4.1953

Internet

https://doi.org/10.1002/cam4.1953

Similar Items